Aktiesnakken — April 2010
-
Hortens hq er spektakulært
-
Gn er en pyyyrhus sejr
-
Genmab lidt skuffende
-
450 mill i milestones
-
De er på vej i Asien også
-
Nej det kører helt seperat og gsk har ikke været gavmilde med sukkeret
-
haha GEN kursstigningen svarer nøjagtigt til værdien af milestonen. Så meget for salgsforventninger i europa...
-
Milestones er også deferred costs
-
var det ikke kun omsætning på ca. 400 mio de forventede...
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind